Waters Corp.

0LTI London Stock Exchange Healthcare & Biotech United States
3.08 £
3.34 %

Waters Corporation designs and manufactures analytical instruments for the pharmaceutical, environmental, and food industries.

Performance & Momentum

6 Months
1 Year 19.68 %
3 Years 6.57 %
5 Years 14.84 %

Strategic Analysis

Waters Corp. occupies a specialized position in analytical instruments, with a strong foothold in chromatography and quality control for laboratories and the pharmaceutical industry. Its business model is based on highly technical equipment and consumables integrated into critical, recurring use cases, which gives it a defensive niche within healthcare and life sciences.

Strengths
  • Recognized specialist position in analytical solutions essential to laboratories
  • Exposure to recurring and regulated uses, particularly in pharmaceuticals and quality control
  • Differentiated technological base in chromatography and precision instrumentation
Weaknesses
  • Sensitivity to the investment cycle of laboratories and industrial customers
  • Dependence on the dynamics of the pharmaceutical sector and research budgets
Momentum

Momentum appears moderately positive, with a recent rebound after a more pronounced period of pressure on medium-term performance. The stock seems to be evolving in a stabilization pattern rather than one of strong acceleration, suggesting a gradual recovery profile that remains dependent on a clearer return in demand for laboratory instruments.

Similar stocks to Waters Corp.

Anantys Community

Be the first to share your analysis on Waters Corp..

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases